EP0874846B1
(en)
*
|
1995-11-01 |
2003-04-02 |
Novartis AG |
Purine derivatives and processes for their preparation
|
FR2741881B1
(fr)
*
|
1995-12-01 |
1999-07-30 |
Centre Nat Rech Scient |
Nouveaux derives de purine possedant notamment des prorietes anti-proliferatives et leurs applications biologiques
|
US6790958B2
(en)
*
|
1996-08-02 |
2004-09-14 |
Robert T. Lum |
Purine inhibitors of cyclin dependent kinase 2 & IKBA
|
WO1998016528A1
(en)
|
1996-10-11 |
1998-04-23 |
Chiron Corporation |
Purine inhibitors of glycogen synthase kinase 3 (gsk3)
|
DE19653646A1
(de)
*
|
1996-12-20 |
1998-06-25 |
Hoechst Ag |
Substituierte Purinderivate, Verfahren zu deren Herstellung, sie enthaltende Mittel und deren Verwendung
|
DE69832715T2
(de)
*
|
1997-07-12 |
2007-01-11 |
Cancer Research Technology Ltd. |
Cyclin-abhängige-kinase inhibierende purinderivate
|
US6573044B1
(en)
*
|
1997-08-07 |
2003-06-03 |
The Regents Of The University Of California |
Methods of using chemical libraries to search for new kinase inhibitors
|
US6255485B1
(en)
*
|
1997-08-07 |
2001-07-03 |
The Regents Of The University Of California |
Purine inhibitors of protein kinases, G proteins and polymerases
|
US6333155B1
(en)
|
1997-12-19 |
2001-12-25 |
Affymetrix, Inc. |
Exploiting genomics in the search for new drugs
|
EP1418244A1
(en)
*
|
1997-12-19 |
2004-05-12 |
Affymetrix, Inc. |
Exploiting genomics in the search for new drugs
|
US6479487B1
(en)
*
|
1998-02-26 |
2002-11-12 |
Aventis Pharmaceuticals Inc. |
6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
|
US6642231B2
(en)
*
|
1998-02-26 |
2003-11-04 |
Aventis Pharmaceuticals Inc. |
6,9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
|
US6413974B1
(en)
|
1998-02-26 |
2002-07-02 |
Aventis Pharmaceuticals Inc. |
6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
|
US6221873B1
(en)
|
1998-03-04 |
2001-04-24 |
Institute Of Experimental Botany Of The Academy Of Sciences Of The Czech Republic |
Cyclin dependent kinase inhibitor
|
US6703395B2
(en)
|
1998-03-04 |
2004-03-09 |
Institute Of Experimental Botany Of The Academy Of Sciences Of The Czech Republic |
Cyclin dependent kinase inhibitor
|
GB9806739D0
(en)
*
|
1998-03-28 |
1998-05-27 |
Univ Newcastle Ventures Ltd |
Cyclin dependent kinase inhibitors
|
CA2335115C
(en)
*
|
1998-06-16 |
2009-01-27 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Fused azepinone cyclin dependent kinase inhibitors
|
US6559152B2
(en)
|
1998-10-13 |
2003-05-06 |
Dupont Pharmaceuticals Company |
6-substituted pyrazolo[3,4-d]pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
|
US6531477B1
(en)
*
|
1998-10-13 |
2003-03-11 |
Dupont Pharmaceuticals Company |
6-substituted pyrazolo [3,4-d] pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
|
KR100377138B1
(ko)
*
|
1998-11-10 |
2003-06-12 |
주식회사 엘지생명과학 |
퓨린구조를갖는싸이클린의존키나아제저해제,그제조방법및그를함유하는항암제조성물
|
CZ27399A3
(cs)
*
|
1999-01-26 |
2000-08-16 |
Ústav Experimentální Botaniky Av Čr |
Substituované dusíkaté heterocyklické deriváty, způsob jejich přípravy, tyto deriváty pro použití jako léčiva, farmaceutická kompozice a kombinovaný farmaceutický přípravek tyto deriváty obsahující a použití těchto derivátů pro výrobu léčiv
|
AU2004200192B2
(en)
*
|
1999-02-01 |
2006-11-16 |
Gilead Palo Alto, Inc. |
Purine inhibitors of cyclin dependent kinase 2 and 1k-Aa
|
ATE306487T1
(de)
*
|
1999-02-01 |
2005-10-15 |
Cv Therapeutics Inc |
Purinhemmer von cyclinabhängiger kinase 2 und ikb-alpha
|
KR100368515B1
(ko)
*
|
1999-02-03 |
2003-01-24 |
주식회사 엘지생명과학 |
싸이클린 의존 키나아제 저해제 및 그의 제조 방법
|
KR20000055080A
(ko)
*
|
1999-02-03 |
2000-09-05 |
성재갑 |
싸이클린 의존 키나아제 저해제 및 그의 제조 방법
|
GB9903762D0
(en)
|
1999-02-18 |
1999-04-14 |
Novartis Ag |
Organic compounds
|
GB9904933D0
(en)
|
1999-03-04 |
1999-04-28 |
Glaxo Group Ltd |
Compounds
|
US6624171B1
(en)
|
1999-03-04 |
2003-09-23 |
Smithkline Beecham Corporation |
Substituted aza-oxindole derivatives
|
US6969720B2
(en)
|
1999-03-17 |
2005-11-29 |
Amr Technology, Inc. |
Biaryl substituted purine derivatives as potent antiproliferative agents
|
US6627633B2
(en)
*
|
1999-03-17 |
2003-09-30 |
Albany Molecular Research, Inc. |
6-substituted biaryl purine derivatives as potent cyclin/CDK inhibitors and antiproliferative agents
|
FR2793794B1
(fr)
*
|
1999-05-21 |
2001-07-27 |
Hoechst Marion Roussel Inc |
Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
|
DE50010931D1
(de)
|
1999-06-23 |
2005-09-15 |
Aventis Pharma Gmbh |
Substituierte benzimidazole
|
GB9918035D0
(en)
|
1999-07-30 |
1999-09-29 |
Novartis Ag |
Organic compounds
|
US20020132819A1
(en)
*
|
1999-12-17 |
2002-09-19 |
Metcalf Chester A. |
Novel purinse
|
IL150594A0
(en)
*
|
2000-01-07 |
2003-02-12 |
Ustav Ex Botan Adademie Ved Ce |
Purine derivatives, process for their preparation and use
|
KR20010077073A
(ko)
*
|
2000-01-31 |
2001-08-17 |
박호군 |
C-2,6,9 위치에 치환된 이소프로필퓨린 유도체 및그의 제조 방법
|
GB0016877D0
(en)
*
|
2000-07-11 |
2000-08-30 |
Astrazeneca Ab |
Chemical compounds
|
US6861524B2
(en)
|
2000-10-31 |
2005-03-01 |
Aventis Pharmaceuticals Inc. |
Acyl and sulfonyl derivatives of 6,9-disubstituted 2-(trans-1,4-diaminocyclohexyl)-purines and their use as antiproliferative agents
|
US20040048849A1
(en)
*
|
2000-12-20 |
2004-03-11 |
Gregoire Prevost |
Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors
|
FR2818278B1
(fr)
*
|
2000-12-20 |
2003-02-28 |
Sod Conseils Rech Applic |
Inhibiteurs de kinases dependantes des cyclines (cdk) et de la glycogene synthase kinase-3 (gsk-3)
|
FR2818642B1
(fr)
*
|
2000-12-26 |
2005-07-15 |
Hoechst Marion Roussel Inc |
Nouveaux derives de la purine, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilistion
|
US7605175B2
(en)
|
2001-03-02 |
2009-10-20 |
Gpc Biotech Ag |
Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
|
US6667311B2
(en)
|
2001-09-11 |
2003-12-23 |
Albany Molecular Research, Inc. |
Nitrogen substituted biaryl purine derivatives as potent antiproliferative agents
|
US6812232B2
(en)
|
2001-09-11 |
2004-11-02 |
Amr Technology, Inc. |
Heterocycle substituted purine derivatives as potent antiproliferative agents
|
AU2002342051B2
(en)
*
|
2001-10-12 |
2009-06-11 |
Irm Llc |
Kinase inhibitor scaffolds and methods for their preparation
|
AU2002357295A1
(en)
*
|
2001-12-18 |
2003-06-30 |
Cv Therapeutics, Inc. |
A2a adenosine receptor antagonists
|
SI1764118T1
(sl)
*
|
2002-02-15 |
2010-11-30 |
Gilead Palo Alto Inc |
Polimerna prevleka za medicinske priprave
|
MXPA04007776A
(es)
|
2002-03-13 |
2004-10-15 |
Janssen Pharmaceutica Nv |
Derivados de sulfonilamino como nuevos inhibidores de histona deacetilasa.
|
EP1485353B1
(en)
|
2002-03-13 |
2011-08-24 |
Janssen Pharmaceutica NV |
New inhibitors of histone deacetylase
|
GB0219054D0
(en)
*
|
2002-08-15 |
2002-09-25 |
Cyclacel Ltd |
New purine derivatives
|
GB0219052D0
(en)
*
|
2002-08-15 |
2002-09-25 |
Cyclacel Ltd |
New puring derivatives
|
GB0219746D0
(en)
*
|
2002-08-23 |
2002-10-02 |
Inst Of Ex Botany Ascr |
Azapurine derivatives
|
US7273864B2
(en)
*
|
2002-10-15 |
2007-09-25 |
The Scripps Research Institute |
Compositions and methods for inducing osteogenesis
|
EP1611136A2
(en)
|
2003-04-07 |
2006-01-04 |
GPC Biotech Inc. |
Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
|
KR100573861B1
(ko)
*
|
2003-07-18 |
2006-04-25 |
경동제약 주식회사 |
2-아미노-9-(2-할로게노에틸)푸린 및 그 중간체로서의 2-아미노-6,8-디클로로-9-(2-히드록시에틸)푸린의 제조방법
|
CN100447143C
(zh)
*
|
2003-08-15 |
2008-12-31 |
Irm责任有限公司 |
作为rtk抑制剂的6-取代的苯胺基嘌呤
|
EP1656378A4
(en)
*
|
2003-08-15 |
2011-05-11 |
Irm Llc |
COMPOUNDS AND COMPOSITIONS INHIBITING TYROSINE KINASE RECEPTOR ACTIVITY
|
AU2004274185B2
(en)
|
2003-09-25 |
2009-12-10 |
Janssen Pharmaceutica N.V. |
HIV replication inhibiting purine derivatives
|
AU2004309415B2
(en)
|
2003-12-23 |
2010-08-26 |
Agennix Usa Inc. |
Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
|
JP2006056879A
(ja)
*
|
2004-07-21 |
2006-03-02 |
Kobe Univ |
インスリン抵抗性の改善剤、及びそのスクリーニング方法
|
AP2336A
(en)
|
2004-07-28 |
2011-12-08 |
Janssen Pharmaceutica Nv |
Subsituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase.
|
GB0419175D0
(en)
*
|
2004-08-27 |
2004-09-29 |
Cyclacel Ltd |
Method of treatment and compositions
|
AU2005276231A1
(en)
*
|
2004-08-27 |
2006-03-02 |
Cyclacel Limited |
Purine and pyrimidine CDK inhibitors and their use for the treatment of autoimmune diseases
|
PL1802625T3
(pl)
|
2004-10-13 |
2008-12-31 |
Hoffmann La Roche |
Dwupodstawione pirazolobenzodiazepiny użyteczne jako inhibitory CDK2 i angiogenezy oraz w leczeniu raka sutka, okrężnicy, płuca i gruczołu krokowego
|
EP1837033A4
(en)
*
|
2004-11-12 |
2010-05-26 |
Kazuhito Tomizawa |
MEDICINE AGAINST DIABETES CONTAINING A Cdk5 INHIBITOR
|
KR100677396B1
(ko)
*
|
2004-11-20 |
2007-02-02 |
엘지전자 주식회사 |
음성인식장치의 음성구간 검출방법
|
MX2007014297A
(es)
*
|
2005-05-16 |
2008-04-21 |
Prometic Biosciences Inc |
Derivados de purina y su uso para el tratamiento de enfermedades autoinmunes.
|
WO2007021937A2
(en)
|
2005-08-11 |
2007-02-22 |
Ariad Pharmaceuticals, Inc. |
Unsaturated heterocyclic derivatives
|
JP2009516753A
(ja)
*
|
2005-11-22 |
2009-04-23 |
ザ スクリップス リサーチ インスティテュート |
高度に効力を持つエポチロンの化学合成
|
CA2630717C
(en)
|
2006-01-19 |
2015-02-24 |
Janssen Pharmaceutica N.V. |
Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
|
ES2426448T3
(es)
|
2006-01-27 |
2013-10-23 |
Shanghai Hengrui Pharmaceutical Co. Ltd. |
Inhibidores de proteína quinasa de pirrolo[3,2-c]piridin-4-ona 2-indolinona
|
GB0606283D0
(en)
*
|
2006-03-29 |
2006-05-10 |
Cyclacel Ltd |
Process
|
WO2008106128A2
(en)
*
|
2007-02-26 |
2008-09-04 |
Vitae Pharmaceuticals, Inc. |
CYCLIC UREA AND CARBAMATE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
|
GB0706632D0
(en)
*
|
2007-04-04 |
2007-05-16 |
Cyclacel Ltd |
New purine derivatives
|
WO2008135232A1
(en)
*
|
2007-05-02 |
2008-11-13 |
Riccardo Cortese |
Use and compositions of purine derivatives for the treatment of proliferative disorders
|
UA99459C2
(en)
*
|
2007-05-04 |
2012-08-27 |
Астразенека Аб |
9-(pyrazol-3-yl)- 9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidazo[4,5-b]pyridin-5-amine derivatives and their use for the treatment of cancer
|
WO2008138232A1
(fr)
|
2007-05-14 |
2008-11-20 |
Shanghai Hengrui Pharmaceutical Co., Ltd. |
Dérivés pyrrolo-azotés hétérocycliques, leur préparation et leur utilisation pharmaceutique
|
WO2008138184A1
(fr)
|
2007-05-14 |
2008-11-20 |
Shanghai Hengrui Pharmaceutical Co.Ltd. |
Dérivés de pyrrolo-azacycles, leur procédé de fabrication et leur utilisation en tant qu'inhibiteurs de protéine kinases
|
ES2395081T3
(es)
*
|
2007-07-26 |
2013-02-08 |
Vitae Pharmaceuticals, Inc. |
Síntesis de inhibidores de la 11beta-hidroxiesteroide deshidrogenasa de tipo 1
|
FR2920776B1
(fr)
*
|
2007-09-12 |
2012-09-28 |
Centre Nat Rech Scient |
Utilisation de derives de purine pour la fabrication d'un medicament
|
EP2215090B1
(en)
*
|
2007-10-26 |
2015-03-04 |
F. Hoffmann-La Roche AG |
Purine derivatives useful as pi3 kinase inhibitors
|
AR069207A1
(es)
*
|
2007-11-07 |
2010-01-06 |
Vitae Pharmaceuticals Inc |
Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
|
WO2009075835A1
(en)
|
2007-12-11 |
2009-06-18 |
Vitae Pharmaceutical, Inc |
CYCLIC UREA INHIBITORS OF 11β-HYDROXYSTEROID DEHYDROGENASE 1
|
TW200934490A
(en)
*
|
2008-01-07 |
2009-08-16 |
Vitae Pharmaceuticals Inc |
Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
|
CA2712500A1
(en)
*
|
2008-01-24 |
2009-07-30 |
Vitae Pharmaceuticals, Inc. |
Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
WO2009102428A2
(en)
*
|
2008-02-11 |
2009-08-20 |
Vitae Pharmaceuticals, Inc. |
1,3-OXAZEPAN-2-ONE AND 1,3-DIAZEPAN-2-ONE INHIBITORS OF 11β -HYDROXYSTEROID DEHYDROGENASE 1
|
WO2009102460A2
(en)
*
|
2008-02-15 |
2009-08-20 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
CA2718264A1
(en)
*
|
2008-03-18 |
2009-09-24 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
|
EP2300461B1
(en)
*
|
2008-05-01 |
2013-04-17 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
JP5538365B2
(ja)
|
2008-05-01 |
2014-07-02 |
ヴァイティー ファーマシューティカルズ,インコーポレイテッド |
11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状阻害剤
|
JP5451752B2
(ja)
*
|
2008-05-01 |
2014-03-26 |
ヴァイティー ファーマシューティカルズ,インコーポレイテッド |
11β−ヒドロキシステロイドデヒドロゲナーゼ1の環状インヒビター
|
US8569292B2
(en)
|
2008-05-01 |
2013-10-29 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
|
BRPI0909614A2
(pt)
*
|
2008-05-30 |
2015-09-22 |
Hoffmann La Roche |
"composto, composição farmacêutica, método de tratamento de um transtorno hiperproliferativo em um mamífero, processo para a preparação de uma composição farmacêutica, método para a inibição ou modulação da atividade de quinase de lipídio em um mamífero, kit para o tratamento de condição mediada por pi3k e método de preparação de um composto da fórmula
|
CN104193740A
(zh)
|
2008-07-03 |
2014-12-10 |
西特里斯药业公司 |
作为沉默调节蛋白调节剂的苯并咪唑类和相关的类似物
|
RU2539979C2
(ru)
|
2008-07-25 |
2015-01-27 |
Вайтаи Фармасьютиклз, Инк. |
Циклические ингибиторы 11бета-гидроксистероид-дегидрогеназы 1
|
JP5777030B2
(ja)
|
2008-07-25 |
2015-09-09 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
11β−ヒドロキシステロイドデヒドロゲナーゼ1の阻害剤
|
WO2010056311A1
(en)
|
2008-11-12 |
2010-05-20 |
Ariad Pharmaceuticals, Inc. |
Pyrazinopyrazines and derivatives as kinase inhibitors
|
CZ302122B6
(cs)
*
|
2009-01-28 |
2010-10-20 |
Univerzita Palackého v Olomouci |
Substituované deriváty 6-(2-aminobenzylamino)purinu, jejich použití jako léciva a prípravky tyto slouceniny obsahující
|
WO2010089303A1
(en)
|
2009-02-04 |
2010-08-12 |
Boehringer Ingelheim International Gmbh |
CYCLIC INHIBITORS OF 11 β-HYDROXYSTEROID DEHYDROGENASE 1
|
EP2396004A4
(en)
|
2009-02-11 |
2012-07-25 |
Reaction Biology Corp |
SELECTIVE KINASE HEMMER
|
WO2010103473A1
(en)
*
|
2009-03-10 |
2010-09-16 |
Chu De Brest |
Method of treatment of polycystic diseases and chronic lymphocytic leukemia
|
DK2414362T3
(da)
*
|
2009-04-03 |
2014-09-22 |
Verastem Inc |
Pyrimidinsubstituerede purinforbindelser som kinaseinhibitorer
|
TW201039034A
(en)
*
|
2009-04-27 |
2010-11-01 |
Chunghwa Picture Tubes Ltd |
Pixel structure and the method of forming the same
|
KR20120061771A
(ko)
*
|
2009-04-30 |
2012-06-13 |
비타이 파마슈티컬즈, 인코포레이티드 |
11베타-하이드록시스테로이드 탈수소효소 1의 고리형 억제제
|
UA109255C2
(ru)
|
2009-04-30 |
2015-08-10 |
Берінгер Інгельхайм Інтернешнл Гмбх |
Циклические ингибиторы 11бета-гидроксистероиддегидрогеназы 1
|
EP2440537A1
(en)
|
2009-06-11 |
2012-04-18 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 based on the 1,3 -oxazinan- 2 -one structure
|
CA2766100C
(en)
|
2009-06-29 |
2018-05-22 |
Incyte Corporation |
Pyrimidinones as pi3k inhibitors
|
WO2011002910A1
(en)
|
2009-07-01 |
2011-01-06 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
US8680108B2
(en)
*
|
2009-12-18 |
2014-03-25 |
Incyte Corporation |
Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors
|
US8759359B2
(en)
|
2009-12-18 |
2014-06-24 |
Incyte Corporation |
Substituted heteroaryl fused derivatives as PI3K inhibitors
|
US9180127B2
(en)
|
2009-12-29 |
2015-11-10 |
Dana-Farber Cancer Institute, Inc. |
Type II Raf kinase inhibitors
|
WO2011106168A1
(en)
*
|
2010-02-24 |
2011-09-01 |
Dcam Pharma Inc |
Purine compounds for treating autoimmune and demyelinating diseases
|
AR081823A1
(es)
|
2010-04-14 |
2012-10-24 |
Incyte Corp |
DERIVADOS FUSIONADOS COMO INHIBIDORES DE PI3Kd
|
EP3399026B1
(en)
|
2010-06-14 |
2024-06-26 |
The Scripps Research Institute |
Reprogramming of cells to a new fate
|
WO2011159760A1
(en)
|
2010-06-16 |
2011-12-22 |
Vitae Pharmaceuticals, Inc. |
Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
|
WO2011163195A1
(en)
|
2010-06-21 |
2011-12-29 |
Incyte Corporation |
Fused pyrrole derivatives as pi3k inhibitors
|
JP5813106B2
(ja)
|
2010-06-25 |
2015-11-17 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
代謝障害の処置のための11−β−HSD1のインヒビターとしてのアザスピロヘキサノン
|
KR101531117B1
(ko)
|
2010-07-14 |
2015-06-23 |
에프. 호프만-라 로슈 아게 |
Pi3k p110 델타에 대해 선택적인 퓨린 화합물, 및 사용 방법
|
WO2012051296A2
(en)
*
|
2010-10-12 |
2012-04-19 |
Case Western Reserve University |
Purine-based triazoles
|
EP2635268A1
(en)
|
2010-11-02 |
2013-09-11 |
Boehringer Ingelheim International GmbH |
Pharmaceutical combinations for the treatment of metabolic disorders
|
EP3053925A1
(en)
|
2010-12-16 |
2016-08-10 |
F. Hoffmann-La Roche AG |
Tricyclic pi3k inhibitor compounds and methods of use
|
ES2764848T3
(es)
|
2010-12-20 |
2020-06-04 |
Incyte Holdings Corp |
N-(1-(fenilo sustituido)etilo)-9H-purina-6-aminas como inhibidores de PI3K
|
WO2012125629A1
(en)
|
2011-03-14 |
2012-09-20 |
Incyte Corporation |
Substituted diamino-pyrimidine and diamino-pyridine derivatives as pi3k inhibitors
|
WO2012135009A1
(en)
|
2011-03-25 |
2012-10-04 |
Incyte Corporation |
Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
|
SI2751109T1
(sl)
|
2011-09-02 |
2017-03-31 |
Incyte Holdings Corporation |
Heterociklilamini kot inhibitorji pi3k
|
CN103814030A
(zh)
*
|
2011-09-22 |
2014-05-21 |
辉瑞大药厂 |
吡咯并嘧啶及嘌呤衍生物
|
CA2856291C
(en)
|
2011-11-17 |
2020-08-11 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of c-jun-n-terminal kinase (jnk)
|
WO2013113762A1
(en)
|
2012-01-31 |
2013-08-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods and kits for predicting the risk of having a cutaneous melanoma in a subject
|
AR090548A1
(es)
|
2012-04-02 |
2014-11-19 |
Incyte Corp |
Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
|
EP2664619B1
(en)
*
|
2012-05-16 |
2017-07-12 |
Manros Therapeutics |
Purine derivatives as tools for screening anti-Alzheimer compounds
|
FR3011240A1
(fr)
|
2013-10-01 |
2015-04-03 |
Centre Nat Rech Scient |
Inhibiteurs de 5'-nucleotidases et leurs utilisations therapeutiques
|
EP3057956B1
(en)
|
2013-10-18 |
2021-05-05 |
Dana-Farber Cancer Institute, Inc. |
Polycyclic inhibitors of cyclin-dependent kinase 7 (cdk7)
|
UA115388C2
(uk)
|
2013-11-21 |
2017-10-25 |
Пфайзер Інк. |
2,6-заміщені пуринові похідні та їх застосування в лікуванні проліферативних захворювань
|
CN104086551B
(zh)
*
|
2014-06-06 |
2016-09-21 |
人福医药集团股份公司 |
化合物及其制备方法和用途
|
WO2015191677A1
(en)
|
2014-06-11 |
2015-12-17 |
Incyte Corporation |
Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
|
WO2016105528A2
(en)
|
2014-12-23 |
2016-06-30 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
HUE060953T2
(hu)
|
2015-02-27 |
2023-04-28 |
Incyte Holdings Corp |
Eljárások PI3K inhibitor elõállítására
|
JP6861166B2
(ja)
*
|
2015-03-27 |
2021-04-21 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
サイクリン依存性キナーゼの阻害剤
|
US9732097B2
(en)
|
2015-05-11 |
2017-08-15 |
Incyte Corporation |
Process for the synthesis of a phosphoinositide 3-kinase inhibitor
|
US9988401B2
(en)
|
2015-05-11 |
2018-06-05 |
Incyte Corporation |
Crystalline forms of a PI3K inhibitor
|
AU2016319125B2
(en)
|
2015-09-09 |
2021-04-08 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
CN108472298B
(zh)
|
2015-11-24 |
2021-04-20 |
深圳阿拉丁医疗科技有限公司 |
选择性激酶抑制剂
|
EP3388432A1
(en)
|
2017-04-10 |
2018-10-17 |
Commissariat à l'Energie Atomique et aux Energies Alternatives |
Purine derivatives for use as medicament and for use in treating neurodegenerative or neuro-inflammatory disorders
|
WO2023140640A1
(ko)
*
|
2022-01-21 |
2023-07-27 |
한양대학교 산학협력단 |
헤테로아릴 유도체 및 이의 용도
|
CN117659016A
(zh)
*
|
2022-08-26 |
2024-03-08 |
嘉兴优博生物技术有限公司 |
细胞周期蛋白调节剂
|